Janssen HL - Search Results

1

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.

van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, Zeuzem S, Lawitz EJ, Rodriguez-Torres M, Kupcova V, Wiercinska-Drapalo A, Hodges MR, Janssen HL, Reesink HW. van der Ree MH, et al. Among authors: janssen hl. Antiviral Res. 2014 Nov;111:53-9. doi: 10.1016/j.antiviral.2014.08.015. Epub 2014 Sep 8. Antiviral Res. 2014. PMID: 25218783 Clinical Trial.

2

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article.

3

Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.

Janssen HL, Kerhof-Los CJ, Heijtink RA, Schalm SW. Janssen HL, et al. Antiviral Res. 1994 Apr;23(3-4):251-7. doi: 10.1016/0166-3542(94)90022-1. Antiviral Res. 1994. PMID: 8042863

4

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

5

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639

6

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

7

Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.

Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. Among authors: janssen hl. J Viral Hepat. 2000 Sep;7(5):382-6. doi: 10.1046/j.1365-2893.2000.00246.x. J Viral Hepat. 2000. PMID: 10971827 Clinical Trial.

8

Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?

van Nunen AB, Janssen HL, Wolters LM, Niesters HG, de Man RA, Schalm SW. van Nunen AB, et al. Among authors: janssen hl. Antiviral Res. 2001 Nov;52(2):139-46. doi: 10.1016/s0166-3542(01)00178-4. Antiviral Res. 2001. PMID: 11672823 Review.

9

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. Among authors: janssen hl. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

10

In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.

Sprengers D, Janssen HL, Kwekkeboom J, Niesters HG, de Man RA, Schalm SW. Sprengers D, et al. Among authors: janssen hl. J Viral Hepat. 2003 Jan;10(1):7-9. doi: 10.1046/j.1365-2893.2003.00395.x. J Viral Hepat. 2003. PMID: 12558905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

631 results

Search Page

Filters